GGrantIndex
← Leaderboards

Simon Lichtiger

Landos Biopharma, Inc.

$1,225,106
Attributed
$1,225,106
Total exposure
1
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $613.2K · FY202022
$1M$750K$500K$250K$0
'20
'21
'22

Funding mix

By agency

NIH$1,225,106 · 1

By mechanism

R01$1,225,106 · 1

Top collaborators

No co-investigators on record.

Others in their field

Other Emerging Leaders on “Design

Research focus

DesignAnti-Inflammatory AgentsAbdominal PainBaseBenignBiological AvailabilityAutoimmune DiseasesAdverse EventBloodBlood SpecimenCanis FamiliarisCd4 Positive T LymphocytesCellsCenters For Disease Control And Prevention (U.S.)Clinical ChemistryClinical InvestigationClinical RemissionClinical ResearchColitisColonC-Reactive ProteinCrohn&AposCytokineDisease Management

Grant awards (2)